Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Fedamycin is a macrolide antibiotic, which has a novel mechanism of action, mainly by inhibiting the RNA polymerase of bacteria to produce rapid anti-Clostridium difficile infection (CDI). Its treatment of CDI is superior to existing drugs.